Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Swedish scientists have characterized a heterogeneous group of neurons in the inner ear, which could inspire new treatments for hearing loss.
Different KRAS mutations exert diverging effects on protein function, a new study illustrates.
A UCSF spinoff is working with GlaxoSmithKline to develop a drug to target a common mutation in glioblastoma.
Machine learning identified mutations in 60 genes that raise the risk of abdominal aortic aneurysm (AAA).
Swedish researchers have found that the rogue SOD1 protein can “transmit” protein misfolding in ALS.
Blocking the interaction between pathological tau proteins and the nuclear membrane of neurons could represent a new approach to Alzheimer's, a new study…
Two new studies suggest new methods for targeting the survival and proliferation of cancer cells.
Using CRISPR to correct a DMD gene mutation restored up to 92% of muscle function in dogs.
Soluble toll-like receptors could hold promise in reversing amyloid plaques.
Implanted iPSC-derived, scaffold-based liver tissues produced promising results in mice with tyrosinemia.